Combination of Venetoclax and Azacytidine As First-Line Induction Therapy for Acute Myeloid Leukemia in Patients Younger Than 60 Years: A Tertiary Care Center Experience from Our Low Middle Income Country
Department
Internal Medicine
Document Type
Conference Proceeding
Publication Title
Blood
Conference Name
ASH Annual Meeting
Conference Date
2023-12-09 - 2023-12-12
First Page
5865
DOI
10.1182/blood-2023-185738
Volume
142
Issue
Supplement 1
Publication Date
11-2-2023
Recommended Citation
Sanjeevi, A., Durairaj, L., Goswami, U., George, D., Subramanian, J., Easow, J. M., Muralikrishnan, S., Muralitharan, N., & Stanislasus, C. (2023). Combination of Venetoclax and Azacytidine As First-Line Induction Therapy for Acute Myeloid Leukemia in Patients Younger Than 60 Years: A Tertiary Care Center Experience from Our Low Middle Income Country. Blood, 142 (Supplement 1), 5865. https://doi.org/10.1182/blood-2023-185738
COinS